Trevi Therapeutics, Inc. TRVI Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate.
The official record: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s effective income tax rate reconciliation at federal statutory income tax rate, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s effective income tax rate reconciliation at federal statutory income tax rate, amount?
- Trevi Therapeutics, Inc. (TRVI) reported effective income tax rate reconciliation at federal statutory income tax rate, amount of -$2.25M in Q4 2025.
- How has Trevi Therapeutics, Inc.'s effective income tax rate reconciliation at federal statutory income tax rate, amount changed year-over-year?
- Trevi Therapeutics, Inc.'s effective income tax rate reconciliation at federal statutory income tax rate, amount increased by 10.7% year-over-year, from -$2.52M to -$2.25M.
- What does effective income tax rate reconciliation at federal statutory income tax rate, amount mean?
- Represents the theoretical income tax expense calculated by applying the federal statutory tax rate to the company's pre-tax income or loss. This serves as the baseline figure in the tax rate reconciliation table before adjustments for permanent differences, credits, or valuation allowances. It helps investors understand the impact of tax planning and structural differences on the effective tax rate.